The application of pathway inhibitors (FAK, Akt, and NF-κB) decreased the proliferation and anti-apoptosis effect of netrin-1 in AML cells, which were detected through CCK-8, flow cytometry, and western blotting. Here, NFKB1 is linked to acute myeloid leukemia.